Metraipolis › archive › dc_cd08ac3a8a18

BHLHE40 Is a Transcriptional Regulatory Target of NFE2L3 in Triple-Negative Breast Cancer — Europe PMC PMID:41613788

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41613788
DOI
10.32604/or.2025.070793
License (as archived)
solo-consultazione
Archived
2026-11-06T17:00:20.777Z
SHA-256 of the archived text
36260206aac97c09e36a72454b4db456db615b89008bca3defe5f1134996b01c
Stable URL of this page
https://metraipolis.com/documento/dc_cd08ac3a8a18

How to cite

BHLHE40 Is a Transcriptional Regulatory Target of NFE2L3 in Triple-Negative Breast Cancer — Europe PMC PMID:41613788 — Europe PMC (en), https://europepmc.org/article/MED/41613788 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd08ac3a8a18 (Metraipolis archive dc_cd08ac3a8a18, sha256 36260206aac97c09e36a72454b4db456db615b89008bca3defe5f1134996b01c)
BibTeX
@misc{dccd08ac3a8a18,
  title = {BHLHE40 Is a Transcriptional Regulatory Target of NFE2L3 in Triple-Negative Breast Cancer — Europe PMC PMID:41613788},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41613788},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd08ac3a8a18; sha256 36260206aac97c09e36a72454b4db456db615b89008bca3defe5f1134996b01c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41613788. Agents can read the archived copy with the MCP tool read_document.